Ameriprise
RXST icon

Ameriprise’s RxSight RXST Stock Holding History

Ameriprise’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Buy
65,156
+39,792
+157% +$240K ﹤0.01% 3824
2026
Q1 		$156K Buy
+25,364
New +$211K ﹤0.01% 3918
2024
Q4 		– Sell
-104,441
Closed -$5.16M – 4151
2024
Q3 		$5.16M Buy
104,441
+61,034
+141% +$3.13M ﹤0.01% 2359
2024
Q2 		$2.61M Sell
43,407
-13,268
-23% -$758K ﹤0.01% 2743
2024
Q1 		$2.92M Buy
56,675
+4,345
+8% +$213K ﹤0.01% 2675
2023
Q4 		$2.11M Sell
52,330
-1,900
-4% -$55.7K ﹤0.01% 2841
2023
Q3 		$1.51M Buy
54,230
+37,325
+221% +$1.11M ﹤0.01% 2956
2023
Q2 		$487K Buy
+16,905
New +$376K ﹤0.01% 3447

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Ameriprise's RXST Position: Q2 2026 in Review

Ameriprise increased its RxSight (RXST) stake by 157% in Q2 2026, buying an estimated $240K and bringing the position to 65,156 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #3824.

Ameriprise first reported a position in RXST in Q2 2023 and has held it in 8 quarters since. The position peaked at $5.16M in Q3 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Ameriprise held 65,156 shares of RxSight worth $314K as of Q2 2026.
  • Ameriprise bought 39,792 RxSight shares in Q2 2026, an estimated $240K.
  • RxSight made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3824 holding.
  • Ameriprise first reported a position in RxSight in Q2 2023 and has held it in 8 quarters since.
  • Ameriprise's RxSight position peaked at $5.16M in Q3 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.